Tissue Regenix Group Future Growth
Future criteria checks 4/6
Tissue Regenix Group is forecast to grow earnings and revenue by 170.8% and 15.1% per annum respectively while EPS is expected to grow by 161% per annum.
Key information
170.8%
Earnings growth rate
161.0%
EPS growth rate
Biotechs earnings growth | 35.4% |
Revenue growth rate | 15.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 40 | 1 | -1 | 4 | 2 |
12/31/2024 | 35 | 0 | -1 | 2 | 2 |
6/30/2024 | 32 | -1 | -1 | 0 | N/A |
3/31/2024 | 31 | -1 | 0 | 1 | N/A |
12/31/2023 | 29 | -2 | 0 | 1 | N/A |
9/30/2023 | 28 | -2 | -1 | 0 | N/A |
6/30/2023 | 27 | -2 | -2 | -1 | N/A |
3/31/2023 | 26 | -2 | -2 | -1 | N/A |
12/31/2022 | 24 | -3 | -2 | -1 | N/A |
9/30/2022 | 23 | -3 | -2 | -1 | N/A |
6/30/2022 | 22 | -4 | -3 | -2 | N/A |
3/31/2022 | 21 | -4 | -4 | -2 | N/A |
12/31/2021 | 20 | -5 | -5 | -3 | N/A |
9/30/2021 | 19 | -8 | -6 | -4 | N/A |
6/30/2021 | 18 | -12 | -8 | -4 | N/A |
3/31/2021 | 17 | -12 | -8 | -5 | N/A |
12/31/2020 | 16 | -12 | -8 | -6 | N/A |
9/30/2020 | 17 | -10 | -8 | -7 | N/A |
6/30/2020 | 16 | -7 | -8 | -7 | N/A |
3/31/2020 | 16 | -8 | -9 | -8 | N/A |
12/31/2019 | 17 | -9 | -10 | -9 | N/A |
9/30/2019 | 15 | -9 | -9 | -8 | N/A |
6/30/2019 | 15 | -10 | -9 | -8 | N/A |
3/31/2019 | 15 | -10 | -9 | -9 | N/A |
12/31/2018 | 15 | -10 | -9 | -9 | N/A |
9/30/2018 | 14 | -11 | -11 | -11 | N/A |
6/30/2018 | 12 | -12 | -13 | -12 | N/A |
3/31/2018 | 10 | -13 | N/A | -13 | N/A |
12/31/2017 | 7 | -12 | N/A | -13 | N/A |
12/31/2016 | 2 | -13 | N/A | -15 | N/A |
7/31/2016 | 2 | -14 | N/A | -15 | N/A |
4/30/2016 | 1 | -15 | N/A | -15 | N/A |
1/31/2016 | 1 | -13 | N/A | -13 | N/A |
10/31/2015 | 1 | -13 | N/A | -13 | N/A |
7/31/2015 | 1 | -12 | N/A | -13 | N/A |
4/30/2015 | 0 | -12 | N/A | -13 | N/A |
1/31/2015 | 0 | -11 | N/A | -12 | N/A |
10/31/2014 | 0 | -12 | N/A | -12 | N/A |
7/31/2014 | 0 | -12 | N/A | -12 | N/A |
4/30/2014 | 0 | -11 | N/A | -11 | N/A |
1/31/2014 | 0 | -9 | N/A | -9 | N/A |
10/31/2013 | 0 | -8 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LSW is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: LSW is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: LSW is expected to become profitable in the next 3 years.
Revenue vs Market: LSW's revenue (15.1% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: LSW's revenue (15.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LSW's Return on Equity is forecast to be high in 3 years time